Abstract:Background: Calcific aortic valve disease (CAVD) is a chronic inflammatory disease that manifests as progressive valvular fibrosis and calcification. An inflammatory milieu in valvular tissue promotes fibrosis and calcification. Aortic valve interstitial cell (AVIC) proliferation and the over-production of the extracellular matrix (ECM) proteins contribute to valvular thickening. However, the mechanism underlying elevated AVIC fibrogenic activity remains unclear. Recently, we observed that AVICs from diseased … Show more
“…[20] Additionally, BMP2 is a marker of vascular cells' osteogenic phenotypic change, which is a critical mechanistic step in the development of CAVD. [21] Kim et al [18] found that COMP can directly bind to the C-terminus of BMP2, as confirmed by Co-IP and GST pull-down assays. Consistently, we found that COMP and BMP2 were co-located in CAVD group valves in this study.…”
Section: Discussionmentioning
confidence: 84%
“…BMP2 and transforming growth factor-β (TGF-β) can mediate biglycan-induced pro-osteogenic reprogramming in aortic valve interstitial cells [20] . Additionally, BMP2 is a marker of vascular cells’ osteogenic phenotypic change, which is a critical mechanistic step in the development of CAVD [21] . Kim et al [18] found that COMP can directly bind to the C-terminus of BMP2, as confirmed by Co-IP and GST pull-down assays.…”
Objective: Calcific aortic valve disease (CAVD) affects millions of elderly people, and there is currently no effective way to stop or slow down its progression. Therefore, exploring the pathogenesis of CAVD is very important for prevention and treatment. Cartilage oligomeric matrix protein (COMP) have important role in cell phenotype change. This study is aimed to confirm whether COMP participate in CAVD and try to find the possible mechanisms.Methods: Human aortic valve tissues from Nanjing First Hospital (CAVD group, n = 20; control group, n = 11) were harvested. The expression level of COMP was tested by western blot and immunohistochemistry. Dual immunofluorescence staining was used for locating COMP. Bone morphogenetic protein-2 (BMP2) signalling were tested by western blot. The animal model was also used to detect COMP level by immunohistochemistry.
Results:The results showed that the expression level of COMP was significantly increased in the calcific valve samples when compared with that of the control valve (P < 0.05); COMP was expressed near the calcific nodules and co-localized with a-smooth muscle actin (a-SMA). The protein levels of BMP2 and p-Smads 1/5/9 were markedly more highly expressed in the CAVD group than the control group (P < 0.05). Furthermore, immunofluorescence detection showed that COMP and BMP2 were co-located in calcific valves.
Conclusions:The above results suggested that upregulation of COMP and BMP2 may be associated with aortic valve calcification and that COMP may become a potential therapeutic target in human CAVD.
“…[20] Additionally, BMP2 is a marker of vascular cells' osteogenic phenotypic change, which is a critical mechanistic step in the development of CAVD. [21] Kim et al [18] found that COMP can directly bind to the C-terminus of BMP2, as confirmed by Co-IP and GST pull-down assays. Consistently, we found that COMP and BMP2 were co-located in CAVD group valves in this study.…”
Section: Discussionmentioning
confidence: 84%
“…BMP2 and transforming growth factor-β (TGF-β) can mediate biglycan-induced pro-osteogenic reprogramming in aortic valve interstitial cells [20] . Additionally, BMP2 is a marker of vascular cells’ osteogenic phenotypic change, which is a critical mechanistic step in the development of CAVD [21] . Kim et al [18] found that COMP can directly bind to the C-terminus of BMP2, as confirmed by Co-IP and GST pull-down assays.…”
Objective: Calcific aortic valve disease (CAVD) affects millions of elderly people, and there is currently no effective way to stop or slow down its progression. Therefore, exploring the pathogenesis of CAVD is very important for prevention and treatment. Cartilage oligomeric matrix protein (COMP) have important role in cell phenotype change. This study is aimed to confirm whether COMP participate in CAVD and try to find the possible mechanisms.Methods: Human aortic valve tissues from Nanjing First Hospital (CAVD group, n = 20; control group, n = 11) were harvested. The expression level of COMP was tested by western blot and immunohistochemistry. Dual immunofluorescence staining was used for locating COMP. Bone morphogenetic protein-2 (BMP2) signalling were tested by western blot. The animal model was also used to detect COMP level by immunohistochemistry.
Results:The results showed that the expression level of COMP was significantly increased in the calcific valve samples when compared with that of the control valve (P < 0.05); COMP was expressed near the calcific nodules and co-localized with a-smooth muscle actin (a-SMA). The protein levels of BMP2 and p-Smads 1/5/9 were markedly more highly expressed in the CAVD group than the control group (P < 0.05). Furthermore, immunofluorescence detection showed that COMP and BMP2 were co-located in calcific valves.
Conclusions:The above results suggested that upregulation of COMP and BMP2 may be associated with aortic valve calcification and that COMP may become a potential therapeutic target in human CAVD.
“…As mentioned before, TLRs and neutrophin 3 are involved in myofibroblast activation (118). Neutrophin neutralization using specific antibodies or inhibition of the downstream signaling was shown to inhibit the activation in vitro; whether a clinical application is thinkable needs to be evaluated.…”
Section: Regression Of Fibrosis Molecular Targets and Potential Pitfalls In Pharmaceutical Interventionsmentioning
confidence: 97%
“…Stimulation of TLR4 with lipopolysaccharide activates the Akt and ERK1/2 pathway and increases the expression of neurotrophin 3. This activation subsequently results in VIC proliferation and increased collagen 3 and MMP9 production with implications for pathological ECM remodeling ( 118 ).…”
Section: Molecular Mechanisms Of Valvular Fibrosis and Potential To Reverse Remodelingmentioning
Calcific aortic valve disease (CAVD) is a highly prevalent and progressive disorder that ultimately causes gradual narrowing of the left ventricular outflow orifice with ensuing devastating hemodynamic effects on the heart. Calcific mineral accumulation is the hallmark pathology defining this process; however, fibrotic extracellular matrix (ECM) remodeling that leads to extensive deposition of fibrous connective tissue and distortion of the valvular microarchitecture similarly has major biomechanical and functional consequences for heart valve function. Significant advances have been made to unravel the complex mechanisms that govern these active, cell-mediated processes, yet the interplay between fibrosis and calcification and the individual contribution to progressive extracellular matrix stiffening require further clarification. Specifically, we discuss (1) the valvular biomechanics and layered ECM composition, (2) patterns in the cellular contribution, temporal onset, and risk factors for valvular fibrosis, (3) imaging valvular fibrosis, (4) biomechanical implications of valvular fibrosis, and (5) molecular mechanisms promoting fibrotic tissue remodeling and the possibility of reverse remodeling. This review explores our current understanding of the cellular and molecular drivers of fibrogenesis and the pathophysiological role of fibrosis in CAVD.
“…Moreover, we observed that human AVICs express functional Toll-like receptors (TLRs), and AVICs isolated from diseased aortic valves have higher levels of TLR2 and TLR4 [10]. More importantly, stimulation of TLRs in human AVICs not only induces inflammatory responses [7][8][9]11], but also elevates cellular osteogenic and fibrogenic activities [8][9][10][12][13][14], and the pro-inflammatory and pro-osteogenic pathways in human AVICs interact to modulate cellular inflammatory and osteogenic activities [15]. Thus, TLRs may play a mechanistic role in mediating CAVD progression [16].…”
Section: Ivyspring International Publishermentioning
Background and Objectives: Chronic valvular inflammation associated with monocyte infiltration promotes calcific aortic valve disease (CAVD) progression. Further, innate immunity in aortic valve interstitial cells (AVICs), mediated by Toll-like receptors (TLRs), up-regulates cellular inflammatory, fibrogenic and osteogenic activities. Currently, the pro-inflammatory communication between monocytes and AVICs and the underlying mechanism are unclear. We hypothesized that monocytes up-regulate AVIC inflammatory activity. This study sought to characterize the interaction between monocytes and AVICs and to elucidate the mechanism underlying cell-to-cell communication. Methods and Results: AVICs, monocytes and co-cultures were exposed to a low concentration of TLR2 activator Pam3CSK4 (0.03 µg/ml). The TLR2 activator at this dose induced a marked increase in AVIC production of ICAM-1 and VCAM-1 only when co-cultured with monocytes. Adding conditioned medium from Pam3CSK4-treated monocytes (Pam3 CM, containing 0.1 µg/ml of Pam3CSK4) to AVIC culture (30% vol/vol; diluting Pam3CSK4 to 0.03 µg/ml) greatly increased the expression of adhesion molecules while adding conditioned medium from untreated monocytes (control CM) had no effect. Inhibition or knockdown of TLR2 in AVICs markedly reduced ICAM-1 and VCAM-1 expression induced by Pam3 CM. Further, Pam3 CM increased TLR2 levels in AVICs. Multiplex-ELISA analysis of Pam3 CM identified greater levels of TNF-α. Neutralization of TNF-α abolished the effect of Pam3 CM on AVIC TLR2 levels, resulting in marked attenuation of its potency in the induction of adhesion molecule expression. Conclusions: This study demonstrates that activated monocytes use paracrine signaling to sensitize AVICs for inflammatory responses to a low level of TLR2 activator. The mechanism of sensitization involves up-regulation of AVIC TLR2 levels by TNF-α from monocytes. Infiltrated monocytes in aortic valve tissue may exacerbate valvular inflammation by rendering AVICs hypersensitive to TLR2 activators.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.